Glycosylated Hemoglobin A1c Assay (Glycosylated Hemoglobin A1c Assay )
- UID
- IMP/IVD/2020/000383_65d781c08abe3dc4d632b27df06e7bcf_55a75f39b28992322d7f4d42a667bee6
- Device class
- Class B
- Brand name
- Blood Culture Positive Sample Pretreatment Kit
- License holder
- BIODX HEALTHCARE
- Approving authority
- CDSCO
- Product information
- The kit is used for the quantitative in vitro detection of Glycosylated Hemoglobin A1c in human whole blood samples
Glycosylated Hemoglobin A1c Assay (Glycosylated Hemoglobin A1c Assay ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000383_65d781c08abe3dc4d632b27df06e7bcf_55a75f39b28992322d7f4d42a667bee6. This device is marketed under the brand name Blood Culture Positive Sample Pretreatment Kit. The license holder is BIODX HEALTHCARE, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.